Prosecution Insights
Prosecution Insights
25 pending office actions • 21 art units • 25 examiners • 0 of 25 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 25 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 25 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 3 (12%) |
| §103 only | 11 (44%) |
| §102 only | 3 (12%) |
| §112 only | 5 (20%) |
| No statute on record | 3 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARR, MARY EVANGELINE | 1 | 36.3% | +31.8% |
| SZUMNY, JONATHON A | 1 | 58.1% | +58.9% |
| GREENE, IVAN A | 1 | 18.7% | +6.6% |
| DAHLIN, HEATHER RAQUEL | 1 | 46.5% | +48.9% |
| REICHERT, RACHELLE LEIGH | 1 | 30.3% | +34.0% |
| COUGHLIN, MATTHEW P | 1 | 71.3% | +11.8% |
| SZNAIDMAN, MARCOS L | 1 | 36.9% | +15.9% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.3% | +24.5% |
| BARRERA, IMMACULADA | 1 | 28.6% | +83.3% |
| RICCI, CRAIG D | 1 | 53.5% | +52.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18506664 | METHOD OF FORMING PEPTIDE-COATED NANOPARTICLES | GREENE, IVAN A | 30d overdue |
| 18261907 | SYSTEMS, METHODS, AND DEVICES, FOR IMPLEMENTING INTERVENTION TREATMENT REGIMENS FOR A POPULATION OF SUBJECTS | REICHERT, RACHELLE LEIGH | 12d |
| 18249999 | SARS-COV-2 ANTIBODIES AND USES THEREOF | BARRERA, IMMACULADA | 28d |
| 17606981 | Elucidating a Proteomic Signature for the Detection of Intracerebral Aneurysms | DUNN, MCKENZIE A | 54d |
| 18002075 | SYSTEMS AND METHODS FOR EVALUATING A SUBJECT FOR INFLAMMATORY BOWEL DISEASE MANAGEMENT | EDOUARD, JONATHAN CHRISTOPHER | 65d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18362634 | CANCER-SELECTIVE TARGET DEGRADATION BY TARGETING GROUP CAGED PROTACS | DAHLIN, HEATHER RAQUEL | 105d overdue |
| 18034965 | METHODS OF TREATING TUMORS AND CANCERS HAVING DYSREGULATED WNT SIGNALING PATHWAYS | WHITE, DAWANNA SHAR-DAY | 98d overdue |
| 18712863 | SYSTEMS AND METHODS FOR ELECTROCARDIOGRAM DEEP LEARNING INTERPRETABILITY | BARR, MARY EVANGELINE | 97d overdue |
| 18249829 | NEW COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | RICCI, CRAIG D | 56d overdue |
| 18251670 | CXCR1/CXCR2 INHIBITORS FOR USE IN TREATING MYELOFIBROSIS | SZNAIDMAN, MARCOS L | 25d overdue |
| 18261907 | SYSTEMS, METHODS, AND DEVICES, FOR IMPLEMENTING INTERVENTION TREATMENT REGIMENS FOR A POPULATION OF SUBJECTS | REICHERT, RACHELLE LEIGH | 12d |
| 18036095 | PHENOTHIAZINE COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AGE-RELATED AND NEUROLOGICAL DISEASES | COUGHLIN, MATTHEW P | 28d |
| 18249999 | SARS-COV-2 ANTIBODIES AND USES THEREOF | BARRERA, IMMACULADA | 28d |
| Art Unit | Apps |
|---|---|
| 3686 | 2 |
| 1629 | 2 |
| 1671 | 2 |
| 1674 | 2 |
| 3682 | 1 |
| 1619 | 1 |
| 1626 | 1 |
| 1628 | 1 |
| 1627 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18712863 | SYSTEMS AND METHODS FOR ELECTROCARDIOGRAM DEEP LEARNING INTERPRETABILITY | BARR, MARY EVANGELINE | 3682 | §103 | Non-Final OA | 97d overdue | Pending | May 23, 2024 |
| 18535430 | SYSTEMS AND METHODS FOR PROCESSING CONNECTIVITY VALUES BETWEEN SUB-PROCESSING REGIONS | SZUMNY, JONATHON A | 3686 | §103 | Final Rejection | 33d | Pending | Dec 11, 2023 |
| 18506664 | METHOD OF FORMING PEPTIDE-COATED NANOPARTICLES | GREENE, IVAN A | 1619 | §103 | Non-Final OA | 30d overdue | Pending | Nov 10, 2023 |
| 18362634 | CANCER-SELECTIVE TARGET DEGRADATION BY TARGETING GROUP CAGED PROTACS | DAHLIN, HEATHER RAQUEL | 1629 | §103 | Non-Final OA | 105d overdue | Pending | Jul 31, 2023 |
| 18261907 | SYSTEMS, METHODS, AND DEVICES, FOR IMPLEMENTING INTERVENTION TREATMENT REGIMENS FOR A POPULATION OF SUBJECTS | REICHERT, RACHELLE LEIGH | 3686 | §101 | Final Rejection | 12d | Pending | Jul 18, 2023 |
| 18036095 | PHENOTHIAZINE COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AGE-RELATED AND NEUROLOGICAL DISEASES | COUGHLIN, MATTHEW P | 1626 | §103 | Non-Final OA | 28d | Pending | May 09, 2023 |
| 18251670 | CXCR1/CXCR2 INHIBITORS FOR USE IN TREATING MYELOFIBROSIS | SZNAIDMAN, MARCOS L | 1628 | §103 | Non-Final OA | 25d overdue | Pending | May 03, 2023 |
| 18034965 | METHODS OF TREATING TUMORS AND CANCERS HAVING DYSREGULATED WNT SIGNALING PATHWAYS | WHITE, DAWANNA SHAR-DAY | 1627 | Other | Non-Final OA | 98d overdue | Pending | May 02, 2023 |
| 18249999 | SARS-COV-2 ANTIBODIES AND USES THEREOF | BARRERA, IMMACULADA | 1671 | §112 | Non-Final OA | 28d | Pending | Apr 21, 2023 |
| 18249829 | NEW COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | RICCI, CRAIG D | 1611 | §102 | Non-Final OA | 56d overdue | Pending | Apr 20, 2023 |
| 18006798 | Compositions and Methods for Treating Infections of the Gastrointestinal Tract | KOROTCHKINA, LIOUBOV G | 1653 | §103 | Final Rejection | 14d | Pending | Jan 25, 2023 |
| 18002075 | SYSTEMS AND METHODS FOR EVALUATING A SUBJECT FOR INFLAMMATORY BOWEL DISEASE MANAGEMENT | EDOUARD, JONATHAN CHRISTOPHER | 3683 | §101 | Final Rejection | 65d | Pending | Dec 16, 2022 |
| 18001516 | SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA | CHEN, PO-CHIH | 1621 | §102 | Non-Final OA | 71d overdue | Pending | Dec 12, 2022 |
| 18009017 | DETACHMENT MECHANISM FOR DETACHABLE-TIP ENDOVASCULAR DEVICES | KHANDKER, RAIHAN R | 3771 | §103 | Non-Final OA | 62d | Pending | Dec 08, 2022 |
| 18008282 | Use of Multi-Kinase Inhibitors to Treat RNA Virus Infections | KIFLE, BRUCK | 1624 | §112 | Non-Final OA | 29d | Pending | Dec 05, 2022 |
| 17922777 | RECOMBINANT NEWCASTLE DISEASE VIRUS EXPRESSING SARS-COV-2-SPIKE PROTEIN AND USES THEREOF | PARKIN, JEFFREY S | 1671 | §103 | Non-Final OA | 30d overdue | Pending | Nov 01, 2022 |
| 17781929 | METHOD OF TREATMENT WITH KCNQ CHANNEL OPENERS | TRAN, ERIC | 1629 | §103 | Final Rejection | 22d | Pending | Jun 02, 2022 |
| 17778598 | SMALL UNANNOTATED, NON-CODING RNAS FOR THE DETECTION OF LIVER CANCER | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §103 | Final Rejection | 6d | Pending | May 20, 2022 |
| 17753708 | ANC80 ENCODING SPHINGOLIPID-METABOLIZING PROTEINS FOR MITIGATING DISEASE-INDUCED TISSUE DAMAGE | PAULUS, ERIN VIRGINIA | 1631 | Other | Non-Final OA | 100d overdue | Pending | Mar 11, 2022 |
| 17633255 | METHOD OF TREATING KELOIDS | MIDDLETON, DANAYA L | 1674 | §102 | Final Rejection | 28d | Pending | Feb 07, 2022 |
| 17616626 | SYSTEMS AND METHODS FOR DIAGNOSTICS FOR BIOLOGICAL DISORDERS ASSOCIATED WITH PERIODIC VARIATIONS IN METAL METABOLISM | ZEMAN, MARY K | 1686 | Other | Non-Final OA | 30d overdue | Pending | Dec 03, 2021 |
| 17606981 | Elucidating a Proteomic Signature for the Detection of Intracerebral Aneurysms | DUNN, MCKENZIE A | 1678 | §101 | Non-Final OA | 54d | Pending | Oct 27, 2021 |
| 17290128 | PEPTIDES, COMPOSITIONS AND VACCINES FOR TREATMENT OF MICROSATELLITE INSTABLITY HYPERMUTATED TUMORS AND METHODS OF USE THEREOF | FAUST, AMBER KATHLEEN | 1643 | §112 | Non-Final OA | 21d | Pending | Apr 29, 2021 |
| 17041006 | METHODS OF TREATING MINIMAL RESIDUAL CANCER | MCCOLLUM, ANDREA K | 1674 | §112 | Final Rejection | 18d overdue | Pending | Sep 24, 2020 |
| 16067099 | FLY AVATARS FOR CANCER AND USES THEREOF | MONTANARI, DAVID A | 1632 | §112 | Non-Final OA | 45d overdue | Pending | Jun 28, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial